What is the size of the Human Antihistamine Drug market in 2023?

The Human Antihistamine Drug market size is USD 274.8 million in 2023.

What is the projected CAGR at which the Human Antihistamine Drug market is expected to grow at?

The Human Antihistamine Drug market is expected to grow at a CAGR of 9.9% (2024-2033).

List the segments encompassed in this report on the Human Antihistamine Drug market?

Market.US has segmented the Human Antihistamine Drug market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Drug Type the market has been segmented into First-Generation Antihistamines, Second-Generation Antihistamines. By Type the market has been segmented into Prescription-based, Over-the-counter (OTC). By Indication the market has been segmented into Urticaria, Allergy, Atopic Dermatitis, Others. By Route of Administration the market has been segmented into Oral, Parenteral, Others. By End-Users the market has been segmented into Hospitals, Specialty Clinics, Homecare, Others.

List the key industry players of the Human Antihistamine Drug market?

Sanofi, Johnson & Johnson, GlaxoSmithKline (GSK), Bayer AG, Pfizer Inc., Novartis International AG, Merck & Co. Inc., Boehringer Ingelheim, Sun Pharmaceutical Industries Ltd., UCB S.A., and Other Key Players

Which region is more appealing for vendors employed in the Human Antihistamine Drug market?

North America is expected to account for the highest revenue share of 37.2% and boasting an impressive market value of USD 102.2 million. Therefore, the Human Antihistamine Drug industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Human Antihistamine Drug?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Human Antihistamine Drug Market.

Global Human Antihistamine Drug Market Analysis By Drug Type (First-Generation Antihistamines, Second-Generation Antihistamines), By Type (Prescription-based, Over-the-counter (OTC)), By Indication (Urticaria, Allergy, Atopic Dermatitis, Others), By Route of Administration (Oral, Parenteral, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Dec 2023
Report ID: 83756
Number of Pages: 270
Format:

- Sanofi Company Profile
- Johnson & Johnson
- GlaxoSmithKline (GSK)
- Bayer AG Company Profile
- Pfizer Inc Company Profile
- Novartis AG Company Profile
- Merck & Co. Inc.
- Boehringer Ingelheim
- Sun Pharmaceutical Industries Ltd.
- UCB S.A.
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 83756
Published Date Dec 2023
Rating
- ★★★★★
  
  ★★★★★
- (69)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)